Skip to main content
Clinical Trials/CTRI/2023/10/058216
CTRI/2023/10/058216
Not yet recruiting
未知

Probiotic supplementation in improving symptom control among children with moderate to severe asthma: A double blind randomized trial - NI

DrNiranjan Biswal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: J454- Moderate persistent asthmaHealth Condition 2: J459- Other and unspecified asthmaHealth Condition 3: J455- Severe persistent asthma
Sponsor
DrNiranjan Biswal
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DrNiranjan Biswal

Eligibility Criteria

Inclusion Criteria

  • Children aged 6\-18 years with moderate to severe asthma according to GINA criteria

Exclusion Criteria

  • Known cases of congenital or acquired immunodeficiency, cystic fibrosis and chronic pulmonary diseases, Alpha 1 antitrypsin deficiency, congenital heart disease, children with acute exacerbation, active respiratory infection.

Outcomes

Primary Outcomes

Not specified

Similar Trials